Richard S. Bedlack, MD, PhD, MS
Director, Duke ALS Clinic
Department / Division
Medicine /
Medicine-Neurology
Address
DUMC 3333
Durham, NC 27710
Appointment Telephone
919-668-7600
Office Telephone
919-668-2839
Fax Telephone
919-668-2901
- MD, PhD, University of Connecticut School of Medicine, 1995
- Neurology, Duke University Medical Center, 1996-1999
- Neuromuscular Disease, Duke University Medical Center, 1999-2000
- MS, Clinical Research, Duke University Medical Center, 2004
Clinical Interests
Amyotrophic lateral sclerosis and other motor neuron diseases
Research Interests
1. Investigator-initiated and multi-center clinical trials testing new treatments for amyotrophic lateral sclerosis and diabetic neuropathy.
2. Epidemiologic studies to better understand the causes and variability in prognosis of amyotrophic lateral sclerosis and diabetic neuropathy.
3. Basic science studies to develop novel biomarkers for amyotrophic lateral sclerosis.
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- ALS Association
- Athena Diagnostics (Quest Diagnostics Inc.)
- Avanir Pharmaceuticals (paid by Curry Rockefellar Group)
- Biogen Idec Inc.
- Clinipace
- Coleman Research Group
- Easton Associates
- Eli Lilly & Co.
- Gerson Lehrman Group, Inc.
- Guidepoint Global
- Health Advances
- Leerink Swann and Company
- Massachusetts General Hospital (Partners Healthcare)
- Pfizer Inc.
- Sanofi-Aventis
- UCB Pharma
Representative Publications
Bedlack, RS; Traynor, BJ; Cudkowicz, ME. Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opinion on Emerging Drugs. 2007;12:229-252.
(2007)
Abstract
Gordon, PH; Moore, DH; Miller, RG; Florence, JM; Verheijde, JL; Doorish, C; Hilton, JF; Spitalny, GM; MacArthur, RB; Mitsumoto, H; Neville, HE; Boylan, K; Mozaffar, T; Belsh, JM; Ravits, J; Bedlack, RS; Graves, MC; McCluskey, LF; Barohn, RJ; Tandan, R; Western ALS Study Group. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurology. 2007;6:1045-1053.
(2007)
Abstract
